Catalyst Wire Dossier Catalyst Wire Dossier

TNP-2092 for Injection

TNP-2092 · TenNor Therapeutics Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TNP-2092 for Injection, covering 2024-05-01 to 2024-05-01. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1, Single-Dose and Multiple-Dose Continuous Intravenous Infusions of TNP-2092 for Injection in Healthy Chinese Participants [Phase 1]

See pricing